Glück Conviction Score™ ⓘ
MAZE
Maze Therapeutics, Inc.
ⓘ
Eingeschränkte Aussagekraft — erst 63 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv: Risiko-Ausstieg
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
44,2
52 neu, 59 erhöht, -287272K $ netto
Aktivist
34,3
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 26.09 | -7.8 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 33.60 | -28.4 % vs SMA200 | |
| SMA-Cross | Bärisch | 10 % | DEATH | vor 17 Tagen @ 24.46 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 24.99 | EMA50: 27.79 | |
| MACD-Histogramm | Bullisch | 10 % | 0.021 | Bullisch | |
| RSI(14) | Neutral | 10 % | 40.0 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 32.8 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 23.0 | +DI: 13.6 / −DI: 22.8 | |
| Z-Score(60) | Neutral | 5 % | -0.68 | In Range | |
| 52W-Position | Neutral | 5 % | 33.1 % | Hoch 51.84 / Tief 10.33 | |
| Bollinger(20,2σ) | Neutral | 5 % | 24.5 % | Upper 26.85 / Mid 25.00 / Lower 23.14 | |
| LinReg-Slope(60) | Bärisch | 10 % | -0.2181 | R²=0.42 / annualisiert -196.1 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Coloma Jason V | Director, Officer, Chief Executive Officer | Open Market Sale | -6.090 | 26,20 | -159.536,69 | -56,1% | |
| 2026-06-01 | Coloma Jason V | Director, Officer, Chief Executive Officer | Open Market Sale | -553 | 26,24 | -14.511,38 | -5,1% | |
| 2026-06-01 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -13.253 | 25,57 | -338.940,17 | -119,1% | |
| 2026-06-01 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -1.600 | 26,36 | -42.172,16 | -14,8% | |
| 2026-05-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -7.500 | 26,34 | -197.553,75 | -69,4% | |
| 2026-05-26 | Coloma Jason V | Director, Officer, Chief Executive Officer | Open Market Sale | -25.582 | 26,02 | -665.515,73 | -233,8% | |
| 2026-05-22 | Coloma Jason V | Director, Officer, Chief Executive Officer | Open Market Sale | -4.504 | 26,00 | -117.104,45 | -41,1% | |
| 2026-05-22 | Coloma Jason V | Director, Officer, Chief Executive Officer | Open Market Sale | -2.478 | 26,00 | -64.428,00 | -22,6% | |
| 2026-05-15 | Coloma Jason V | Director, Officer, Chief Executive Officer | Open Market Sale | -1.822 | 26,00 | -47.372,00 | -16,6% | |
| 2026-05-15 | Coloma Jason V | Director, Officer, Chief Executive Officer | Open Market Sale | -116 | 26,00 | -3.016,00 | -1,1% | |
| 2026-05-14 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -15.000 | 26,22 | -393.354,00 | -138,2% | |
| 2026-04-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -7.500 | 25,37 | -190.299,00 | -66,9% | |
| 2026-04-01 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -3.348 | 30,06 | -100.635,86 | -35,4% | |
| 2026-04-01 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -2.200 | 29,32 | -64.509,94 | -22,7% | |
| 2026-04-01 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -300 | 30,34 | -9.101,01 | -3,2% | |
| 2026-04-01 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -11.352 | 29,24 | -331.948,37 | -116,6% | |
| 2026-04-01 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -300 | 31,07 | -9.320,01 | -3,3% | |
| 2026-03-30 | Dandekar Atul | Officer, CSBO | Open Market Sale | -6.710 | 29,26 | -196.305,08 | -69,0% | |
| 2026-03-30 | Dandekar Atul | Officer, CSBO | Open Market Sale | -790 | 30,02 | -23.713,67 | -8,3% | |
| 2026-03-20 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -5.044 | 50,02 | -252.293,82 | -88,6% | |
| 2026-03-20 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -6.161 | 48,20 | -296.976,83 | -104,3% | |
| 2026-03-20 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -3.795 | 49,32 | -187.168,64 | -65,8% | |
| 2026-03-10 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -29.652 | 50,45 | -1.495.807,00 | -525,5% | |
| 2026-03-10 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -348 | 51,02 | -17.753,22 | -6,2% | |
| 2026-03-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -3.700 | 45,47 | -168.236,78 | -59,1% | |
| 2026-03-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -1.300 | 44,44 | -57.773,82 | -20,3% | |
| 2026-02-27 | Dandekar Atul | Officer, CSBO | Open Market Sale | -3.739 | 45,13 | -168.756,03 | -59,3% | |
| 2026-02-27 | Dandekar Atul | Officer, CSBO | Open Market Sale | -3.761 | 45,72 | -171.967,21 | -60,4% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -5.936 | 46,37 | -275.271,32 | -96,7% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -600 | 44,21 | -26.523,00 | -9,3% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -100 | 47,23 | -4.723,00 | -1,7% | |
| 2026-02-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -4.064 | 46,03 | -187.067,95 | -65,7% | |
| 2026-02-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -736 | 46,63 | -34.321,37 | -12,1% | |
| 2026-02-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -200 | 44,15 | -8.830,00 | -3,1% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -8.364 | 45,89 | -383.816,43 | -134,8% | |
| 2026-01-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -3.500 | 44,04 | -154.146,65 | -54,2% | |
| 2026-01-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -2.800 | 45,01 | -126.022,40 | -44,3% | |
| 2026-01-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -1.200 | 43,18 | -51.821,28 | -18,2% | |
| 2026-01-22 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -5.000 | 45,52 | -227.612,00 | -80,0% | |
| 2026-01-07 | Sohn Catherine A. | Director | Open Market Sale | -26.920 | 39,11 | -1.052.784,67 | -369,9% | |
| 2026-01-07 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -25.156 | 40,20 | -1.011.298,87 | -355,3% | |
| 2026-01-06 | Sohn Catherine A. | Director | Open Market Sale | -2.493 | 38,62 | -96.269,69 | -33,8% | |
| 2026-01-05 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -412 | 40,00 | -16.480,00 | -5,8% | |
| 2026-01-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -2.595 | 39,57 | -102.681,30 | -36,1% | |
| 2026-01-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -4.432 | 40,43 | -179.187,53 | -63,0% | |
| 2026-01-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -2.405 | 38,70 | -93.072,30 | -32,7% | |
| 2025-12-30 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -5.000 | 40,08 | -200.407,00 | -70,4% | |
| 2025-12-30 | Dandekar Atul | Officer, CSBO | Open Market Sale | -100 | 40,36 | -4.036,00 | -1,4% | |
| 2025-12-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -6.035 | 41,13 | -248.211,10 | -87,2% | |
| 2025-12-29 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -27.800 | 40,34 | -1.121.424,20 | -394,0% | |
| 2025-12-29 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -17.200 | 40,93 | -703.930,64 | -247,3% | |
| 2025-12-29 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -9.400 | 40,54 | -381.071,30 | -133,9% | |
| 2025-12-29 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -600 | 41,16 | -24.694,98 | -8,7% | |
| 2025-12-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -66.365 | 40,51 | -2.688.552,33 | -944,6% | |
| 2025-09-15 | SCHELLER RICHARD H | Director | Open Market Sale | -20.744 | 22,37 | -464.034,98 | -163,0% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 4.567.274 | 4.567.274 | 0 | 136.333.129 | Unverändert | 0,0% | |
| TRV GP IV, LLC | 4.473.958 | 4.473.958 | 0 | 133.547.646 | Unverändert | 0,0% | |
| ARCH Venture Management, LLC | 4.120.053 | 0 | 4.120.053 | 122.983.582 | Neu | +100,0% | |
| Deep Track Capital, LP | 3.477.562 | 4.246.440 | -768.878 | 103.805.226 | Reduziert | -18,1% | |
| JANUS HENDERSON GROUP PLC | 2.858.876 | 3.142.587 | -283.711 | 85.280.271 | Reduziert | -9,0% | |
| Paradigm Biocapital Advisors LP | 2.744.399 | 0 | 2.744.399 | 81.920.310 | Neu | +100,0% | |
| BlackRock, Inc. | 2.570.425 | 2.287.155 | 283.270 | 76.727.187 | Aufgestockt | +12,4% | |
| VANGUARD GROUP INC | 1.697.015 | 0 | 1.697.015 | 70.307.332 | Neu | +100,0% | |
| a16z Capital Management, L.L.C. | 1.702.225 | 1.702.225 | 0 | 50.811.416 | Unverändert | 0,0% | |
| Venrock Adviser, LLC | 1.602.034 | 1.548.569 | 53.465 | 47.820.715 | Aufgestockt | +3,5% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.435.656 | 0 | 1.435.656 | 42.854.332 | Neu | +100,0% | |
| Alphabet Inc. | 1.388.583 | 1.388.583 | 0 | 41.449.203 | Unverändert | 0,0% | |
| Logos Global Management LP | 1.235.000 | 950.000 | 285.000 | 36.864.750 | Aufgestockt | +30,0% | |
| Bellevue Group AG | 887.708 | 0 | 887.708 | 36.777.742 | Neu | +100,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.178.000 | 0 | 1.178.000 | 35.163.300 | Neu | +100,0% | |
| General Catalyst Group Management, LLC | 1.035.910 | 1.035.910 | 0 | 30.921.914 | Unverändert | 0,0% | |
| TRV GP V, LLC | 950.800 | 950.800 | 0 | 28.381.380 | Unverändert | 0,0% | |
| FMR LLC | 864.214 | 728.605 | 135.609 | 25.796.788 | Aufgestockt | +18,6% | |
| CITADEL ADVISORS LLC | 809.214 | 448.217 | 360.997 | 24.155.038 | Aufgestockt | +80,5% | |
| ArrowMark Colorado Holdings LLC | 767.383 | 767.383 | 0 | 22.906.383 | Unverändert | 0,0% | |
| Casdin Capital, LLC | 758.857 | 758.857 | 0 | 22.651.881 | Unverändert | 0,0% | |
| Cormorant Asset Management, LP | 750.000 | 0 | 750.000 | 22.387.500 | Neu | +100,0% | |
| Squadron Capital Management LLC | 490.000 | 0 | 490.000 | 20.300.700 | Neu | +100,0% | |
| Matrix Capital Management Company, LP | 480.000 | 0 | 480.000 | 19.886.400 | Neu | +100,0% | |
| Woodline Partners LP | 650.229 | 1.035.229 | -385.000 | 19.409.336 | Reduziert | -37,2% | |
| STATE STREET CORP | 636.722 | 533.005 | 103.717 | 19.006.152 | Aufgestockt | +19,5% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 636.162 | 378.015 | 258.147 | 18.989.436 | Aufgestockt | +68,3% | |
| Caligan Partners LP | 614.962 | 550.191 | 64.771 | 18.356.616 | Aufgestockt | +11,8% | |
| GEODE CAPITAL MANAGEMENT, LLC | 599.967 | 527.281 | 72.686 | 17.912.855 | Aufgestockt | +13,8% | |
| BALYASNY ASSET MANAGEMENT L.P. | 461.151 | 199.212 | 261.939 | 13.765.357 | Aufgestockt | +131,5% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 324.041 | 0 | 324.041 | 13.425.019 | Neu | +100,0% | |
| Ikarian Capital, LLC | 393.399 | 644.680 | -251.281 | 11.742.960 | Reduziert | -39,0% | |
| FARALLON CAPITAL MANAGEMENT LLC | 373.000 | 0 | 373.000 | 11.134.050 | Neu | +100,0% | |
| HHLR ADVISORS, LTD. | 366.028 | 457.535 | -91.507 | 10.925.936 | Reduziert | -20,0% | |
| MARSHALL WACE, LLP | 310.639 | 847.472 | -536.833 | 9.272.574 | Reduziert | -63,3% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 284.476 | 409.372 | -124.896 | 8.491.609 | Reduziert | -30,5% | |
| WASHINGTON UNIVERSITY | 280.802 | 280.802 | 0 | 8.381.940 | Unverändert | 0,0% | |
| GOLDMAN SACHS GROUP INC | 279.713 | 114.455 | 165.258 | 8.349.433 | Aufgestockt | +144,4% | |
| Candriam S.C.A. | 278.167 | 0 | 278.167 | 8.303.285 | Neu | +100,0% | |
| TCG Crossover Management, LLC | 173.816 | 0 | 173.816 | 7.201.197 | Neu | +100,0% | |
| Mass General Brigham, Inc | 239.994 | 239.994 | 0 | 7.163.821 | Unverändert | 0,0% | |
| Freestone Grove Partners LP | 234.953 | 118.876 | 116.077 | 7.013.347 | Aufgestockt | +97,6% | |
| SPHERA FUNDS MANAGEMENT LTD. | 227.343 | 71.843 | 155.500 | 6.786.189 | Aufgestockt | +216,4% | |
| Aberdeen Group plc | 226.227 | 0 | 226.227 | 6.752.876 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 211.382 | 176.259 | 35.123 | 6.309.753 | Aufgestockt | +19,9% | |
| MORGAN STANLEY | 204.831 | 258.086 | -53.255 | 6.114.205 | Reduziert | -20,6% | |
| Spruce Street Capital LP | 200.000 | 0 | 200.000 | 5.970.000 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 195.084 | 18.381 | 176.703 | 5.823.258 | Aufgestockt | +961,3% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 186.433 | 175.969 | 10.464 | 5.565.025 | Aufgestockt | +5,9% | |
| Ensign Peak Advisors, Inc | 185.794 | 185.794 | 0 | 5.545.951 | Unverändert | 0,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 4.567.274 | 4.567.274 | 0,0% | 136.333.129 | 8,97 |
| TRV GP IV, LLC | 4.473.958 | 4.473.958 | 0,0% | 133.547.646 | 8,79 |
| ARCH Venture Management, LLC | 4.120.053 | 0 | +100,0% | 122.983.582 | 8,10 |
| Deep Track Capital, LP | 3.477.562 | 4.246.440 | -18,1% | 103.805.226 | 6,83 |
| JANUS HENDERSON GROUP PLC | 2.858.876 | 3.142.587 | -9,0% | 85.280.271 | 5,61 |
| Paradigm Biocapital Advisors LP | 2.744.399 | 0 | +100,0% | 81.920.310 | 5,39 |
| BlackRock, Inc. | 2.570.425 | 2.287.155 | +12,4% | 76.727.187 | 5,05 |
| a16z Capital Management, L.L.C. | 1.702.225 | 1.702.225 | 0,0% | 50.811.416 | 3,34 |
| Venrock Adviser, LLC | 1.602.034 | 1.548.569 | +3,5% | 47.820.715 | 3,15 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.435.656 | 0 | +100,0% | 42.854.332 | 2,82 |
| Alphabet Inc. | 1.388.583 | 1.388.583 | 0,0% | 41.449.203 | 2,73 |
| Logos Global Management LP | 1.235.000 | 950.000 | +30,0% | 36.864.750 | 2,43 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.178.000 | 0 | +100,0% | 35.163.300 | 2,31 |
| General Catalyst Group Management, LLC | 1.035.910 | 1.035.910 | 0,0% | 30.921.914 | 2,04 |
| TRV GP V, LLC | 950.800 | 950.800 | 0,0% | 28.381.380 | 1,87 |
| FMR LLC | 864.214 | 728.605 | +18,6% | 25.796.788 | 1,70 |
| CITADEL ADVISORS LLC | 809.214 | 448.217 | +80,5% | 24.155.038 | 1,59 |
| ArrowMark Colorado Holdings LLC | 767.383 | 767.383 | 0,0% | 22.906.383 | 1,51 |
| Casdin Capital, LLC | 758.857 | 758.857 | 0,0% | 22.651.881 | 1,49 |
| Cormorant Asset Management, LP | 750.000 | 0 | +100,0% | 22.387.500 | 1,47 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 167 | 56,8 | 1.679 |
| 31.12.2025 | ✓ | 144 | 44,8 | 1.830 |
| 30.09.2025 | ✓ | 93 | 39,1 | 1.001 |
| 30.06.2025 | ✓ | 73 | 38,8 | 470 |
| 31.03.2025 | ✓ | 66 | 38,4 | 434 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Bellevue Group AG | 887.708 | 36.777.742 |
| Caligan Partners LP | 550.191 | 22.794.413 |
| Squadron Capital Management LLC | 490.000 | 20.300.700 |
| CITADEL ADVISORS LLC | 448.217 | 18.569.630 |
| EVENTIDE ASSET MANAGEMENT, LLC | 324.041 | 13.425.019 |
| Mass General Brigham, Inc | 239.994 | 9.942.951 |
| TCG Crossover Management, LLC | 173.816 | 7.201.197 |
| HighVista Strategies LLC | 170.353 | 7.057.724 |
| MILLENNIUM MANAGEMENT LLC | 154.470 | 6.399.692 |
| STEMPOINT CAPITAL LP | 125.877 | 5.215.084 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 3.142.587 | 2.390.713 | +318.0 % | 130.197.379 |
| BlackRock, Inc. | 2.287.155 | 971.139 | +73.8 % | 94.756.831 |
| VANGUARD GROUP INC | 1.697.015 | 362.060 | +27.1 % | 70.307.332 |
| Venrock Adviser, LLC | 1.548.569 | 317.800 | +25.8 % | 64.157.214 |
| Deep Track Capital, LP | 4.246.440 | 297.530 | +7.5 % | 175.930.009 |
| ArrowMark Colorado Holdings LLC | 767.383 | 222.251 | +40.8 % | 31.792.678 |
| ADAR1 Capital Management, LLC | 179.532 | 153.487 | +589.3 % | 7.438.011 |
| STATE STREET CORP | 533.005 | 148.303 | +38.6 % | 22.082.397 |
| Ensign Peak Advisors, Inc | 185.794 | 115.129 | +162.9 % | 7.697.445 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 115.711 | 105.237 | +1004.7 % | 4.794 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| TRV GP IV, LLC | 4.473.958 | -1.600.000 | -26.3 % | 185.356.080 |
| Matrix Capital Management Company, LP | 480.000 | -1.173.684 | -71.0 % | 19.886.400 |
| Alphabet Inc. | 1.388.583 | -1.023.888 | -42.4 % | 57.528.994 |
| Logos Global Management LP | 950.000 | -277.300 | -22.6 % | 39.358.500 |
| BALYASNY ASSET MANAGEMENT L.P. | 199.212 | -234.513 | -54.1 % | 8.253.353 |
| Ikarian Capital, LLC | 644.680 | -96.145 | -13.0 % | 26.709.093 |
| SPHERA FUNDS MANAGEMENT LTD. | 71.843 | -82.500 | -53.5 % | 2.976.455 |
| Schonfeld Strategic Advisors LLC | 48.200 | -65.849 | -57.7 % | 1.996.925 |
| RENAISSANCE TECHNOLOGIES LLC | 27.100 | -59.000 | -68.5 % | 1.122.753 |
| ALLIANCEBERNSTEIN L.P. | 33.220 | -26.880 | -44.7 % | 1.376.305 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 5,80 % | 2.858.876 | -1,50 pp | |
| 01.04.2026 | Paradigm BioCapital International Fund Ltd. | Passiv (13G) | 5,40 % | 2.688.520 | Neu | |
| 01.04.2026 | Senai Asefaw, M.D. | Passiv (13G) | 6,10 % | 3.051.087 | Neu | |
| 01.04.2026 | Paradigm BioCapital Advisors LP | Passiv (13G) | 6,10 % | 3.051.087 | Neu | |
| 01.04.2026 | Paradigm BioCapital Advisors GP LLC | Passiv (13G) | 6,10 % | 3.051.087 | Neu | |
| 13.02.2026 | FHMLS XII, L.L.C. | Passiv (13G/A) | Ausstieg | 0 | Neu | |
| 13.02.2026 | Patrick J. Heron | Passiv (13G/A) | 0,20 % | 75.982 | 0,00 pp | |
| 13.02.2026 | FHMLSP, L.L.C. | Passiv (13G/A) | 9,00 % | 4.342.266 | +1,30 pp | |
| 13.02.2026 | FHMLS XI, L.P. | Passiv (13G/A) | 0,30 % | 149.026 | 0,00 pp | |
| 13.02.2026 | Frazier Life Sciences X, L.P. | Passiv (13G/A) | 0,20 % | 75.982 | 0,00 pp | |
| 13.02.2026 | FHMLS XII, L.P. | Passiv (13G/A) | Ausstieg | 0 | Neu | |
| 13.02.2026 | FHMLS X, L.L.C. | Passiv (13G/A) | 0,20 % | 75.982 | 0,00 pp | |
| 13.02.2026 | Frazier Life Sciences Public Fund, L.P. | Passiv (13G/A) | 9,00 % | 4.342.266 | +1,30 pp | |
| 13.02.2026 | Frazier Life Sciences XI, L.P. | Passiv (13G/A) | 0,30 % | 149.026 | 0,00 pp | |
| 13.02.2026 | FHMLS XI, L.L.C. | Passiv (13G/A) | 0,30 % | 149.026 | 0,00 pp | |
| 13.02.2026 | Frazier Life Sciences XII, L.P. | Passiv (13G/A) | Ausstieg | 0 | Neu | |
| 13.02.2026 | FHMLS X, L.P. | Passiv (13G/A) | 0,20 % | 75.982 | 0,00 pp | |
| 13.02.2026 | FHMLSP, L.P. | Passiv (13G/A) | 9,00 % | 4.342.266 | +1,30 pp | |
| 13.02.2026 | James N. Topper | Passiv (13G/A) | 0,20 % | 75.982 | 0,00 pp | |
| 13.02.2026 | Third Rock Ventures IV, L.P. | Passiv (13G/A) | 9,30 % | 4.473.958 | -4,60 pp | |
| 13.02.2026 | Third Rock Ventures GP IV, L.P. | Passiv (13G/A) | 9,30 % | 4.473.958 | -4,60 pp | |
| 13.02.2026 | Third Rock Ventures V, L.P. | Passiv (13G/A) | 2,00 % | 950.800 | -0,20 pp | |
| 13.02.2026 | TRV GP IV, LLC | Passiv (13G/A) | 9,30 % | 4.473.958 | -4,60 pp | |
| 13.02.2026 | TRV GP V, LLC | Passiv (13G/A) | 2,00 % | 950.800 | -0,20 pp | |
| 13.02.2026 | Third Rock Ventures GP V, L.P. | Passiv (13G/A) | 2,00 % | 950.800 | -0,20 pp | |
| 06.02.2026 | GV 2019, L.P. | Passiv (13G/A) | 1,60 % | 784.019 | -2,50 pp | |
| 06.02.2026 | GV 2023, L.P. | Passiv (13G/A) | 1,30 % | 604.564 | -0,10 pp | |
| 06.02.2026 | GV 2019 GP, L.P. | Passiv (13G/A) | 1,60 % | 784.019 | -2,50 pp | |
| 06.02.2026 | Alphabet Holdings LLC | Passiv (13G/A) | 2,90 % | 1.388.583 | -2,60 pp | |
| 06.02.2026 | GV 2019 GP, L.L.C. | Passiv (13G/A) | 1,60 % | 784.019 | -2,50 pp | |
| 06.02.2026 | GV 2023 GP, L.L.C. | Passiv (13G/A) | 1,30 % | 604.564 | -0,10 pp | |
| 06.02.2026 | XXVI Holdings Inc. | Passiv (13G/A) | 2,90 % | 1.388.583 | -2,60 pp | |
| 06.02.2026 | GV 2023 GP, L.P. | Passiv (13G/A) | 1,30 % | 604.564 | -0,10 pp | |
| 06.02.2026 | Alphabet Inc. | Passiv (13G/A) | 2,90 % | 1.388.583 | -2,60 pp | |
| 14.11.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 7,30 % | 3.206.472 | +1,30 pp | |
| 14.11.2025 | Foresite Capital Management V, LLC | Passiv (13G/A) | 0,20 % | 86.291 | -0,60 pp | |
| 14.11.2025 | Foresite Capital Management IV, LLC | Passiv (13G/A) | 1,20 % | 522.657 | -3,60 pp | |
| 14.11.2025 | Foresite Capital Fund V, L.P. | Passiv (13G/A) | 0,20 % | 86.291 | -0,60 pp | |
| 14.11.2025 | James Tananbaum | Passiv (13G/A) | 1,40 % | 608.948 | -4,20 pp | |
| 14.11.2025 | Foresite Capital Fund IV, L.P. | Passiv (13G/A) | 1,20 % | 522.657 | -3,60 pp |
Stammdaten
Maze Therapeutics, Inc., ein Biopharmaunternehmen im klinischen Stadium, entwickelt Kleinmolekül-Präzisionsmedikamente zur Behandlung von Nieren-, Herz-Kreislauf- und damit verbundenen Stoffwechselerkrankungen sowie Adipositas in den Vereinigten Staaten. Seine führenden Programme umfassen MZE829, einen oralen Kleinmolekül-Inhibitor von Apolipoprotein L1, der sich in Phase-II-Kliniktrial für die Behandlung von Patienten mit APOL1-Nierenkrankheit befindet, und MZE782, einen oralen Kleinmolekül-Inhibitor des Lösungsmitteltransporters SLC6A19, der sich in Phase-I-Kliniktrial für die Behandlung von chronischer Nierenkrankheit befindet. Maze Therapeutics, Inc. war zuvor als Modulus Therapeutics, Inc. bekannt und änderte seinen Namen im September 2018 zu Maze Therapeutics, Inc. Das Unternehmen wurde 2017 gegründet und hat seinen Sitz in South San Francisco, Kalifornien.
Unternehmen & Branche
| Name | Maze Therapeutics, Inc. |
|---|---|
| Ticker | MAZE |
| CIK | 0001842295 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 578784100 |
|---|---|
| ISIN | US5787841007 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,19 Mrd. USD |
Bewertung
| KBV (P/B) | 3,35 |
|---|---|
| FCF-Rendite | -9,5 % |
Qualität & Bilanz
| ROIC | -34,7 % |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2024. Kennzahlen erklärt →
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 20.000.000 | -24.208.000 | -0,45 | 419.710.000 | 341.701.000 |
| 2025-12-31 | 10-K | 0 | -131.120.000 | -3,05 | 397.127.000 | 354.966.000 |
| 2025-09-30 | 10-Q | 0 | -30.087.000 | -0,66 | 422.058.000 | 379.436.000 |
| 2025-06-30 | 10-Q | 0 | -33.679.000 | -0,77 | 303.519.000 | 262.238.000 |
| 2025-03-31 | 10-Q | -32.786.000 | -1,15 | 332.840.000 | 292.068.000 | |
| 2024-12-31 | 10-K | 167.500.000 | 52.231.000 | 1,25 | 240.542.000 | -311.183.000 |
| 2024-09-30 | 10-Q | 2.500.000 | -24.752.000 | -10,25 | ||
| 2024-06-30 | 10-Q | 165.000.000 | 139.056.000 | 3,22 | ||
| 2024-03-31 | 10-Q | -32.494.000 | -13,91 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 12.05.2026 | 20,0 Mio. USD | -0,45 |
| Q3 2025 | 30.09.2025 | 06.11.2025 | – | -0,66 |
| Q2 2025 | 30.06.2025 | 06.11.2025 | 0 USD | -0,77 |
| Q1 2025 | 31.03.2025 | 12.05.2026 | – | -1,15 |
| Q3 2024 | 30.09.2024 | 06.11.2025 | 2,5 Mio. USD | -10,25 |
| Q2 2024 | 30.06.2024 | 06.11.2025 | 165,0 Mio. USD | 3,22 |
| Q1 2024 | 31.03.2024 | 06.11.2025 | – | -13,91 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 12.05.2026 | 10-Q | – | – | SEC » |
| 25.03.2026 | 10-K | 31.12.2025 | 84 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 12.08.2025 | 10-Q | 30.06.2025 | 43 Tage | SEC » |
| 14.05.2025 | 10-Q | 31.03.2025 | 44 Tage | SEC » |
| 31.03.2025 | 10-K | 31.12.2024 | 90 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (25.03.2026)
HOCH Abgang Schlüsselpersonen (25.03.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 25.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.09.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-04-28 | 821 | 26,47 | 21.732 |
| 2026-04-20 | 357 | 28,09 | 10.028 |
| 2026-04-14 | 50.000 | 27,42 | 1.371.000 |
| 2026-04-09 | 250 | 28,09 | 7.023 |
| 2026-04-07 | 17 | 29,00 | 493 |
| 2026-04-01 | 71 | 29,85 | 2.119 |
| 2026-03-31 | 301 | 29,01 | 8.732 |
| 2026-03-27 | 56 | 31,71 | 1.776 |
| 2026-03-25 | 10.522 | 49,00 | 515.578 |
| 2026-03-24 | 7.646 | 49,00 | 374.654 |
| 2026-03-23 | 1.418 | 48,03 | 68.107 |
| 2026-03-20 | 20.307 | 49,43 | 1.003.775 |
| 2026-03-19 | 4.506 | 48,47 | 218.406 |
| 2026-03-11 | 1.954 | 51,06 | 99.771 |
| 2026-03-06 | 44.221 | 45,30 | 2.003.211 |
| 2026-03-05 | 39.742 | 46,48 | 1.847.208 |
| 2026-03-03 | 29.983 | 45,61 | 1.367.525 |
| 2026-02-26 | 371 | 47,23 | 17.522 |
| 2026-02-20 | 45 | 45,04 | 2.027 |
| 2026-02-13 | 2.366 | 47,04 | 111.297 |
| 2026-02-12 | 33.369 | 47,22 | 1.575.684 |
| 2026-02-11 | 4.379 | 48,37 | 211.812 |
| 2026-02-10 | 6.217 | 47,71 | 296.613 |
| 2026-02-06 | 27.413 | 43,95 | 1.204.801 |
| 2026-02-05 | 559 | 48,14 | 26.910 |
| 2026-02-02 | 310 | 43,58 | 13.510 |
| 2026-01-30 | 1.251 | 45,00 | 56.295 |
| 2026-01-29 | 364 | 43,36 | 15.783 |
| 2026-01-28 | 1.151 | 45,34 | 52.186 |
| 2026-01-20 | 25.737 | 40,77 | 1.049.297 |
| 2026-01-13 | 15 | 40,19 | 603 |
| 2026-01-12 | 1.656 | 40,32 | 66.770 |
| 2026-01-06 | 20 | 38,63 | 773 |
| 2026-01-05 | 19.250 | 39,77 | 765.573 |
| 2026-01-02 | 34 | 41,43 | 1.409 |
| 2025-12-30 | 127.228 | 40,55 | 5.159.095 |
| 2025-12-29 | 1.941 | 42,10 | 81.716 |
| 2025-12-26 | 7 | 42,08 | 295 |
| 2025-12-22 | 1.106 | 41,71 | 46.131 |
| 2025-12-15 | 952 | 38,86 | 36.995 |